| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $95M | ||
| $91M |
Buys | $0 | 0 | 0 |
Sells | $15,621 | 1 | 100 |
| HILZ MARK T | COO, Secretary and Director | 0 | $0 | 1 | $15,621 | $-15,621 |
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Over the last 12 months, insiders at HeartSciences Inc. have bought $0 and sold $15,621 worth of HeartSciences Inc. stock.
On average, over the past 5 years, insiders at HeartSciences Inc. have bought $0 and sold $15,621 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2025-07-29 | Sale | HILZ MARK T | COO, Secretary and Director | 4,416 0.2253% | $3.54 | $15,621 | -17.18% |
| Increased Positions | 5 | +50% | 32,917 | +18.79% |
| Decreased Positions | 2 | -20% | 10,291 | -5.87% |
| New Positions | <1 | New | 5,968 | New |
| Sold Out Positions | 2 | Sold Out | 10,291 | Sold Out |
| Total Postitions | 13 | +30% | 197,849 | +12.91% |